Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hip implant under study for Long-Term success

NCT ID NCT05524350

Disease control Sponsor: Societe dEtude, de Recherche et de Fabrication Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking how well a new hip replacement part (the HYPE stem) works and lasts over 10 years. About 180 people with hip disease from arthritis or injury will get the implant. Doctors will use X-rays and surveys to see if the implant stays firmly in place and helps reduce pain and improve movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

180 people

The number who actually took part.

Started

Dec 2017

Expected to finish

Jan 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The expected number of patients in the registry is estimated at 180 patients.The implantation of the total hip prosthesis will be carried out in patients with a hip pathology, in first intention or during a total prosthesis revision. The implant placement will be performed on a continuous series of patients by the investigator according to the eligibility criteria. Post-operative follow-up will be carried out for ten days following the operation, in the hospital concerned. Successive clinical and radiological evaluations will be performed at a date set by the investigator.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male or female * Degenerative or inflammatory hip disease requiring total hip replacement * Primary or secondary osteoarthritis, * Advanced joint destruction resulting from rheumatoid arthritis or traumatic origin, * Avascular fracture or necrosis, * Displaced subcapital and transcervical fracture as well as PAPROSKY stages I to IIB bone defects. * Joint destruction of traumatic origin * Following a previous operation, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemiarthroplasty, total arthroplasty). Exclusion Criteria: * Patient with a psychological, family, sociological or geographical situation likely to hinder compliance with the study protocol and follow-up * Known pregnancy in progress * Breastfeeding * Patient requiring a bone graft * Neurological disorders or other pathology that may influence locomotion * History of sepsis in the hip to be operated on * Short-term vital prognosis

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Avascular necrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

avascular necrosis hip fracture osteoarthritis osteoarthritis, hip rheumatoid arthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hip arthropathy

Contacts and locations

Locations

  • Rouen University Hospital Center

    Rouen, 76000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.